Genomics plc has a major multi-year partnership with Vertex Pharmaceuticals, to use our understanding of human genetics and machine learning to improve the discovery of targets for precision medicines, and to advance the understanding of the clinical impact of human genetic variation and patient stratification in diseases with significant unmet need.

Daniel Vogel joins Genomics plc as Chief Financial Officer, adding international commercial and financial expertise.

Predictive genomics to power the future of population and personalised health.

Genetics is the single biggest predictor of an individual’s risk for many common diseases.

Genomics plc strengthens leadership team with the addition of Mitchell Harris as Chief Strategy Officer and Professor Gil McVean as Chief Information Officer.

Peter discusses AI and breast cancer diagnosis and the potential to use genetics to understand an individual’s risk for all common disease.

The UK has a major opportunity to transform the health and care system to a “Prevention First” model by using new genomic technology.

©BBC 2022, All rights reserved, Used with permission.